Cingulate Inc. (CING) stock

CINGNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as CINGW

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 5/30

$4.64+0.08 (+1.75%)

Close on Nov 11, 2026Market cap $67.47MP/E –Yield –

Cingulate gross margin

Gross margin is gross profit as a percentage of revenue.

Cingulate has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?